SCHEMBL1103530

SCHEMBL1103530

Cc1cc(-c2c3ccccc3c(-c3ccc4ccccc4c3)c3c2cnc2ccccc23)cc(C)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.38
NPC1 O15118 2/20 0.37
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
TOP2A P11388 1/20 0.36
IKBKB O14920 1/20 0.36
ACHE P22303 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GPR3 P46089 1/20 0.36
AURKA O14965 1/20 0.35
AURKB Q96GD4 1/20 0.35
PDPK1 O15530 1/20 0.35
CYP1A2 P05177 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1103524 0.91 NPC1 (0.47) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103498 0.90 MET (0.38) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103531 0.90 ALDH1A1 (0.42) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103719 0.90 KDM4E (0.43) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103452 0.90 KDM4E (0.43) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103263 0.90 TOP2A (0.43) NPC1TOP2AACHEKDM4EGPR3
SCHEMBL1103518 0.89 MET (0.38) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103446 0.88 ESR1 (0.43) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103375 0.88 KDM4E (0.42) METNPC1PIK3CDPIK3CAMTOR
SCHEMBL1103522 0.88 KDM4E (0.42) METNPC1PIK3CDPIK3CAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 MET 4191/4885NPC1 1582/4885PIK3CD 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.